Aeterna Zentaris Total Liabilities 2011-2026 | AEZS

Annual Total Liabilities Aeterna Zentaris

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
21.9 M	2.71 M	4.02 M	27.1 M	23.8 M	22.4 M	23.1 M	25 M	25.4 M	33 M	33 M	42.1 M	74.4 M	79.9 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
79.9 M	2.71 M	31.3 M

Quarterly Total Liabilities Aeterna Zentaris

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	23.2 M	27.1 M	22.1 M	23 M	22.8 M	23.8 M	17.1 M	16.7 M	18 M	22.4 M	23.7 M	23.8 M	-	23.1 M	-	-	-	25 M	-	-	-	25.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
27.1 M	16.7 M	22.5 M

Total Liabilities of other stocks in the Biotechnology industry

Issuer	Total Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.98 B	-	2.43 %	$ 254 M	Germany
Alector ALEC	263 M	$ 2.13	-12.55 %	$ 219 M	USA
Acer Therapeutics ACER	28.4 M	-	2.71 %	$ 14 M	USA
BioCardia BCDA	4.59 M	$ 1.37	6.2 %	$ 29 M	USA
Black Diamond Therapeutics BDTX	39.4 M	$ 2.4	-2.83 %	$ 132 M	USA
BioLineRx Ltd. BLRX	25.4 M	$ 2.8	-1.06 %	$ 908 M	Israel
I-Mab IMAB	707 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	6.45 B	-	-	$ 40.3 B	USA
BioXcel Therapeutics BTAI	131 M	$ 1.64	-1.8 %	$ 4.16 M	USA
AgeX Therapeutics AGE	6.61 M	-	-10.17 %	$ 12.2 K	USA
Biophytis SA BPTS	20.4 M	-	-13.47 %	$ 169 M	France
Aeglea BioTherapeutics AGLE	62.5 M	-	-	$ 1.01 B	USA
BeyondSpring BYSI	48.6 M	$ 1.44	6.3 %	$ 58.1 M	USA
Cabaletta Bio CABA	17.5 M	$ 3.34	0.6 %	$ 3.9 M	USA
AbCellera Biologics ABCL	390 M	$ 3.7	2.49 %	$ 1.11 B	Canada
Applied Genetic Technologies Corporation AGTC	37.2 M	-	-	$ 26.5 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.16 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	6.46 M	-	-18.52 %	$ 27.3 M	Britain
Codexis CDXS	82.1 M	$ 1.05	3.47 %	$ 77.1 M	USA
Cerus Corporation CERS	144 M	$ 2.6	1.56 %	$ 480 M	USA
Certara CERT	494 M	$ 7.17	1.27 %	$ 1.15 B	USA
Cullinan Management CGEM	31.5 M	$ 15.91	2.65 %	$ 931 M	USA
Compugen Ltd. CGEN	18.5 M	$ 2.28	25.97 %	$ 204 M	Israel
ARCA biopharma ABIO	13.8 M	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	395 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	5.38 M	-	4.01 %	$ 150 M	Canada
Coherus BioSciences CHRS	823 M	$ 1.66	-0.9 %	$ 156 M	USA
Adverum Biotechnologies ADVM	109 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	1.1 B	-	-	-	Russia
AIkido Pharma AIKI	7.27 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	75.8 M	-	-	$ 3.67 B	USA
Akouos AKUS	45.1 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	126 M	-	-0.23 %	$ 916 M	USA
Cellectis S.A. CLLS	253 M	$ 3.88	-	$ 116 M	France
Allena Pharmaceuticals ALNA	15.9 M	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	7.8 M	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	5.24 M	-	4.14 %	$ 49.1 M	USA
Alpine Immune Sciences ALPN	107 M	-	-	$ 2.17 B	USA
Ampio Pharmaceuticals AMPE	2.38 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	46.6 M	-	-	$ 10.1 M	USA
CNS Pharmaceuticals CNSP	2.52 M	$ 3.1	-0.44 %	$ 1.18 M	USA
Aravive ARAV	51.5 M	-	-13.39 %	$ 1.45 M	USA
Cocrystal Pharma COCP	3.93 M	$ 1.02	-0.97 %	$ 10.4 M	USA
Aptose Biosciences APTO	14.7 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	28.4 M	-	-39.0 %	$ 4.57 M	USA
Collegium Pharmaceutical COLL	1.36 B	$ 42.0	0.79 %	$ 1.33 B	USA
Corcept Therapeutics Incorporated CORT	189 M	$ 35.61	-0.25 %	$ 3.7 B	USA
Athira Pharma ATHA	13.9 M	-	-	$ 269 M	USA
Aridis Pharmaceuticals ARDS	38.9 M	-	17.91 %	$ 11.1 M	USA